Your session is about to expire
← Back to Search
Procedure
Ultrasound for Thoracic Diseases
N/A
Waitlist Available
Research Sponsored by Nationwide Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 5 minutes of intubation and single lung ventilation device placement
Awards & highlights
Study Summary
This trial will compare the accuracy of two methods for verifying lung isolation during single-lung ventilation in children.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 5 minutes of intubation and single lung ventilation device placement
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 5 minutes of intubation and single lung ventilation device placement
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The accuracy of using ultrasound to assess lung isolation by visualizing lung movement or lack thereof of both the operative and non-operative lung fields.
Time to confirm lung isolation
Trial Design
1Treatment groups
Experimental Treatment
Group I: UltrasonographyExperimental Treatment1 Intervention
Patients requiring single lung ventilation for a surgical procedure will have a bedside ultrasound to evaluate lung isolation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Portable, Point-of-Care Ultrasound
2018
N/A
~50
Find a Location
Who is running the clinical trial?
Nationwide Children's HospitalLead Sponsor
341 Previous Clinical Trials
5,220,462 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- No specific criteria for exclusion.You need to have both lungs working during your surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Ultrasonography
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger